Companies
Observations on the Reneo Pharmaceuticals Inc (NASDAQ:RPHM) Growth Curve
At this price, the stock is -84.91% below its 52-week high of $9.21 and 41.82% above its 52-week low of $0.98. Based on the past
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.